Sarah Harding, MD

Senior Medical Director
Ipsen, London, UK, United Kingdom

Poster(s):

• 400 Section - A randomized, double-blind, head-to-head, crossover study comparing the clinical safety and efficacy of abobotulinumtoxinA with onabotulinumtoxinA when treating adults with upper limb spasticity
  Wednesday, May 20, 2026

  6:00 PM - 7:30 PM PT